MarketLens
Sign Up

Why is AbbVie Investing $380 Million in US Manufacturing

7 months ago
SHARE THIS ON:

Why is AbbVie Investing $380 Million in US Manufacturing

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 week ago

AbbVie joins US government pilot to test drug discount rebates

AbbVie said Friday it will join a US government pilot program testing a new rebate system for discounted medicines, with no financial terms or timeline disclosed.
News•1 months ago

Ipsen Weighs U.S. Manufacturing Investment

Ipsen is weighing a U.S. manufacturing site, joining other European drugmakers shifting new investment across the Atlantic. No timeline, cost, or capacity figures were disclosed.
Stock News•1 months ago

AbbVie's Immunology Franchise: From Skyrizi & Rinvoq to What's Next

AbbVie's immunology franchise is being driven by Skyrizi and Rinvoq, with new indications, acquisitions, and partnerships building the next wave of growth.

Breaking News

View All →

No topics available at the moment

Top Headlines

View More →
Stock News•54 minutes ago

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•1 hour ago

Why the Market Dipped But Meta Platforms (META) Gained Today

Stock News•1 hour ago

Nvidia in 5 Years: Where the Stock Could Be Headed

Stock News•2 hours ago

UK finance minister Healey to target online marketplaces in tax crackdown, The Times reports

Stock News•2 hours ago

Character.AI owes Google and Big Law firms nearly $7M, court filings show